Article
[Metastatic basal cell carcinoma with a SMO gene mutation. A case report].
Arkhiv patologii - 1 Jan 2021
Zverev N P, Lyakhovets A A, Plaksa I L, Khmelkova D N, Isaev A A
Abstract excerpt
The authors describe a clinical case of a patient with metastatic basal cell carcinoma and secondary resistance to vismodegib. A SMO G416E mutation of unknown clinical significance was found in the gene encoding the transmembrane receptor protein Smoothened (SMO) protein, which suggests a defect in the Sonic Hedgehog (SH) pathway and may cause tumor resistance to the prescribed drug. Comprehensive genomic...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
